Pharmaceutical Regulatory Affairs

Pharmaceutical Regulatory Affairs is a critical field that ensures the safe and effective development, approval, and commercialization of pharmaceuticals and medical devices across global markets. This track explores the complex landscape of regulatory guidelinescompliance strategies, and policy frameworks that govern drug development from discovery to post-marketing surveillance.

As regulations continuously evolve across different regions, this track aims to equip professionals with updated knowledge on regulatory submissionsintellectual property rights, and strategies for market authorization in various jurisdictions including the FDA, EMA, CDSCO and others.

    Related Conference of Pharmaceutical Regulatory Affairs

    January 29-30, 2026

    19th World Drug Delivery Summit

    Paris, France
    February 10-11, 2026

    40th World Congress on Pharmacology and Therapeutics

    Barcelona, Spain
    February 23-24, 2026

    3rd World Congress on Biologics and Biosimilars

    London, UK
    March 23-24, 2026

    36th Annual European Pharma Congress

    London, UK
    March 24-25, 2026

    11th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    April 16-17, 2026

    19th European Biosimilars Congress

    Rome, Italy
    April 27-28, 2026

    9th European Biopharma Congress

    Paris, Aland Islands
    May 28-29, 2026

    3rd International Conference on Pharmacognosy

    Madrid, Spain
    July 27-28, 2026

    39th World Congress on Pharmacology

    Rome, Italy
    September 24-25, 2026

    6th World Congress on Rare Diseases & Orphan Drugs

    Paris, France

    Pharmaceutical Regulatory Affairs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in